Yahoo Finance Results
Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure RequirementsPR Newswire via Yahoo FinanceJul 06 20:20 PM
Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured. Consumer Contact: Sandoz and Novartis toll-free at 888-669-6682 from Monday to Friday, 8 a.m. to 8 p.m.
- Investing.com3 days ago
BRIEF-Aequus Extends And Enhances Commercial Agreement To Promote Vistitan In Canada
- Bloomberg22 hours ago
- Market Watch2 hours ago
- Investing.com3 days ago
- Reuters via Yahoo FinanceJul 02 6:08 AM
President Donald Trump said he sees his threat to impose global auto tariffs as his biggest weapon to extract concessions from trading partners, shedding more light on his broader trade policy ...
- Zacks via Yahoo FinanceJul 06 13:16 PM
The biggest news this week was Novartis’ NVS announcement of its plans to spin off its eye care division, Alcon, into a new public company. The Committee for Medicinal Products for Human Use ...
- Associated Press via Yahoo FinanceJul 12 1:27 AM
A twice-convicted killer who wants to die rather than spend his life in prison was about an hour from eating his final meal Wednesday when he found out a Nevada judge had indefinitely delayed ...
- Zacks via Yahoo FinanceJul 18 20:27 PM
Swiss pharma giant Novartis AG NVS reported results for second-quarter 2018, wherein revenues beat estimate, driven by strong performance of Cosentyx and Entresto. However, earnings fell short ...
- Zacks via Yahoo FinanceJul 18 13:47 PM
AbbVie, Inc. ABBV has signed a non-exclusive licensing deal with Mylan MYL regarding the latter’s proposed biosimilar version of AbbVie’s blockbuster arthritis drug, Humira, in the United ...
- Thomson Reuters StreetEvents via Yahoo FinanceJul 19 1:03 AM
Yes, on Gleevec, I think the way to think about it is that in the U.S. and Europe, we are continuing to see declines as you would expect to see in both of those markets. And we are seeing growth ...
- Zacks via Yahoo FinanceJul 16 12:15 PM
Swiss pharma-giant Novartis AG NVS is scheduled to report second-quarter 2018 results on Jul 18. Novartis has an excellent track record. In the last reported quarter, Novartis delivered a positive ...
- Zacks via Yahoo FinanceJul 17 18:20 PM
Tuesday, July 17, 2018 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AT&T ...
Sandoz Inc. company research & investing information. Find executives and the latest company news.
Get directions, reviews and information for Sandoz Inc in Wilson, NC.
Find company research, competitor information, contact details & financial data for Sandoz Inc. Get the latest business insights from D&B Hoovers.
Before the 1996 merger with Ciba-Geigy to form Novartis, Sandoz Pharmaceuticals (Sandoz AG) was a pharmaceutical company headquartered in Basel, Switzerland (as was Ciba-Geigy), and was best known for developing drugs such as Sandimmune for organ transplantation, the antipsychotic Clozaril, Mellaril Tablets and Serentil Tablets for treating ...
Report side effects The safety of our products and health and well-being of our patients are our highest priority. If you would like to report a side effect, or adverse event, involving a Sandoz medicine in the US, please contact us by calling 1-800-525-8747.
A case in which the Court determined that the Biologics Price Competition and Innovation Act of 2009 allows for commercial notice of a “biosimilar product” to be effective if given prior to approval by the Food and Drug Administration (FDA), but that the Act’s notice requirement is not enforceable with an injunction.